Key Benefits:
President of the Republic,
On the report of the Prime Minister and the Minister for Foreign Affairs and International Development,
Considering the Constitution, in particular articles 52 to 55;
Vu le Decree No. 53-192 of 14 March 1953 amended on the ratification and publication of international commitments undertaken by France;
Vu le Decree No. 2007-503 of 2 April 2007 publishing the international convention against doping in sport (two annexes), adopted in Paris on 19 October 2005;
Vu le Decree No. 2013-1286 of 27 December 2013 publishing the amendment to the annex to the convention against doping, adopted in Strasbourg on 14 November 2013, and Appendix 1 of the international convention against doping in sport, adopted in Paris on 11 November 2013,
Decrete:
The 2014 list of substances and methods prohibited in sport (version 2, adopted on 1 July 2014) will be published in the Official Journal of the French Republic.
The Prime Minister and the Minister for Foreign Affairs and International Development are responsible, each with respect to him, for the execution of this decree, which will be published in the Official Journal of the French Republic.
LIST 2014
SUBSTANCES AND METHODS IN THE SPORT (VERSION 2, ADOPTED 1 JULY 2014)
CODE MONDIAL ANTIDOPAGE
LIST OF PROHIBITIONS 2014
STANDARD INTERNATIONAL
This list will come into force on 1 September 2014
In accordance with Article 4.2.2 of the World Anti-Doping Code, all prohibited substances must be considered as "specified substances" except substances in classes S1, S2, S4.4, S4.5, S6.a, and prohibited methods Ml, M2 and M3.
SUBSTANCES AND METHODS IN PERMANENCE (EN ET HORS COMPÉTITION)
SUBSTANCES INTERDITES
S0. SUBSTANCES NON APPROVED
Any pharmacological substance not included in a section of the List below and which is not currently approved for therapeutic use in humans by a regulatory health authority (e.g., health regulatory authority). preclinical or clinical development drugs or drugs that are no longer available, medicines in a manner, approved substances only for veterinary use) is permanently prohibited.
S1. ANABOLISANT AGENTS
Anabolic agents are forbidden.
S1.1 Androgenic anabolic steroids (SAA)
a. Exogenous SAA*, including:
1-androstènediol (5α-androst-1-ène-3β,17β-diol); 1-androstènedione (5α-androst-1-ène-3,17-dione) ; bolandiol (estr-4-ène-3β,17β-diol); bolasterone; boldenone; boldione (androsta-1,4-diène-3,17-dione); calusterone; enclosurebol; danazol ([1,2]oxazolo [4',5': 2,3] pregna-4-ène-20-yn-17α-ol); dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-diène-3-one); deoxymethyltestosterone (17α-methyl-5α-androst-2-ène-17β-ol); drostanolone; ethylestrenol (19-norprégna-4-ène-17α-ol) ; fluoxymesterone ; formationbolone ; ferazabol (17α-methyl [1,2.5] oxadiazolo [3',4': 2,3] -5α-androstane-17β-ol); gestrinone; 4-hydroxytestosterone (4,17β-dihydroxyandrost-4-ène-3-one) ; mestanolone ; mesterolone ; metandinone (17β-hydroxy-17α-methylandrosta-1,4-diène-3-one); meternolone; methandriol; methasterone (17β-hydroxy-2α, 17α-dimethy1-5α-androstane-3-one); methyldenolon (17β-hydroxy-17α-methylestra-4,9-diène-3-one); methyl-1-testosterone (17β-hydroxy-17α-methyl-5α-androst-1-ène-3-one); methylnortestosterone (17β-hydroxy-17α-methylestr-4-en-3-one); methyltestosterone; metribolone (methyltrienolone, 17β-hydroxy-17α-methylestra-4,9,11-triene-3-one); mibolone; nandrolone; 19-norandrostendione (estr-4-ene-3,17-dione); norboletone; norclostebol; Norethandrolone ; oxabolone ; oxandrolone ; oximesterrone; oxymetholone; prostanozol (17β [(tétrahydropyrane-2-yl) oxy] -1'H-pyrazolo [3,4: 2,3] -5α-androstane); quinbolone; stanozolol; stenbolone; 1-testosterone (17β-hydroxy-5α-androst-1-ène-3-one) ; tetrahydrogestrinone (17-hydroxy-18a-homo-19-nor-17α-prégna-4,9,11-triène-3-one) ; trenbolone (17β-hydroxyestr-4,9,11-triène-3-one) ; and other substances having a similar chemical structure or biological effect(s) similar(s).
b. Endogenous SAA** by exogenous administration:
androstènediol (androst-5-ène-3β,17β-diol); androstènedione (androst-4-ène-3,17-dione); dihydrotestosterone (17β-hydroxy-5α-androstan-3-one) ; prasterone (dehydroepandrosterone, DHEA, 3β-hydroxyandrost-5-ene-17-one) ; testosterone ; and the following metabolites and isomers, including but not limited to:
5α-androstane-3α,17α-diol; 5α-androstane-3α,17β-diol; 5α-androstane-3β,17α-diol; 5α-androstane-3β,17β-diol; androst-4-ene-3α,17α-diol; androst-4-ene-3α,17β-diol; androst-4-ene-3β,17α-diol; androst-5-ene-3α,17α-diol; androst-5-ene-3α,17β-diol; androst-5-ene-3β,17α-diol; 4-androstènediol (androst-4-ène-3β,17β-diol); 5-androstènedione (androst-5-ène-3,17-dione) ; epi-dihydrotestosterone ; epitestosterone ; etiocholanolone ; 3α-hydroxy-5α-androstan-17-one; 3β-hydroxy-5α-androstan-17-one; 7α-hydroxy-DHEA; 7β-hydroxy-DHEA; 7-keto-DHEA; 19-norandrosterone; 19-norétiocholanolone.
For the purposes of this document:
* "exogenous" means a substance that cannot usually be produced naturally by the human body.
** "endogenous" means a substance that can usually be produced naturally by the human body.
S1.2 Other anabolic agents, including but not limited to:
Clenbuterol, selective modulators of androgenic receptors (SARMs), tibolone, zéranol, zilpatrol.
S2. PEPTIDICAL HORMONS, CROISSANCE FACTERS AND APPROVAL SUBSTANCES
The following substances and other substances with a similar chemical structure or similar biological effects(s) are prohibited:
1. Erythropoiesis stimulants [e.g. erythropoietin (EPO), darbepoetine (DEPO), methoxy polyethylene glycol-epoetin beta (CERA), petginesatide (Hematide), stabilizers and activators of factors inductible by hypoxia (HIF) (e.g. xrgone)
2. chorionic Gonadotrophin (CG) and luteini sante hormone (LH), and their release factors, prohibited in male sports only;
3. Corticotrophins and their factors of liberation;
4. Growth Hormone (GH) and its release factors, and the growth factor similar to insulin-1 (IGF-1);
In addition, the following growth factors are prohibited:
Growth factor derived from platelets (PDGF), vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), fibroblastic growth factors (FGF), mechanical growth factors (MGF), as well as any other growth factor influencing, in muscle, tendon or ligament, protein synthesis/degradation, vascularization
S3. BÊTA-2 AGONISTS
All beta-2 agonists, including all their optical isomers (e.g. d- and 1-) if applicable, are prohibited, except salbutamol inhaled (maximum 1,600 micrograms per 24 hours), inhaled formoterol (maximum dose of 54 micrograms per 24 hours) and salmeterol administered by inhalation in accordance with the recommended patterns of administration
The presence in the urine of salbutamol at a concentration greater than 1000 ng/mL or formoterol at a concentration greater than 40 ng/mL will be presumed not to be an intentional therapeutic use and will be considered as a result of abnormal analysis, unless the athlete proves by a controlled pharmacokinetic study that this abnormal result is the consequence of the use of a maximum dose by inhalation.
S4. HORMONAL AND METHODS
The following substances are prohibited:
1. Aromatase inhibitors, including without limitation: ami-noglutethimide, anastrozole, androsta-1,4,6-trine-3,17-dione (androstatriènedione), 4-androstène-3,6,17 trione (6-oxo), exemestane, formstane, létrozole, testolactone.
2. Selective modulators of receptors to estrogen (SERM), including without limitation: raloxifen, tamoxifen, toremifen.
3. Other anti-estrogogenic substances, including but not limited to: clomifene, cyclofenil, fulvestrant.
4. Modifying agents of myostatin function(s), including without limitation: myostatin inhibitors.
5. Metabolic modulators:
(a) Insulins;
(b) The receptor agonists activated by the proliferators of the δ peroxysomes (PPARδ) (e.g. GW 1516) and the agonists of the PPARδ-protein kinase axis activated by the AMPK (e.g. AICAR).
S5. DIURÉTIQUE ET AUTRES AGENTS MASQUANTS
Agents are forbidden. They include:
Diuretics, desmopressin, probenecide, plasma substitutes (e.g. glycerol; intravenous administration of albumin, dextran, hydroxyethyl stardon and mannitol), and other substances with similar biological effect(s).
The local administration of felypressin in dental anesthesia is not prohibited.
Diuretics include:
Acetazolamide, amiloride, bumetanide, canrenone, chlor-talidone, etacrynic acid, furosemide, indapamide, metolazone, spironolactone, thiazides (e.g. bendroflumethiazide, chlorothiazide, hydrochlorothiazide), triamten, vaptans (e. tolva
The use in competition, and out of competition if applicable, of any quantity of a substance being subject to a threshold level (i.e. formoterol, salbutamol, cathine, ephedrine, methylephedrine and pseudoephedrine) in conjunction with a diuretic or other masking agent requires the issuance of an authorization of use for specific therapeutic purposes for this substance, in addition to that
METHODS
M1 MANIPULATION OF SANGUAGE OR SANGUAGE
The following is prohibited:
1. Administration or reintroduction of any amount of autologous, allogenic (homologist) or heterogeneous blood, or red blood cells of any origin in the circulatory system.
2. Artificial improvement in the consumption, transport or release of oxygen, including, but not limited to, perfluorinated chemicals, efaproxiral (RSR13) and modified hemoglobin products (e.g. blood substitutes based on hemoglobin, reticulated hemoglobin products), but excluding oxygen supplementation.
3. Any intravascular manipulation of blood or blood component(s) by physical or chemical methods.
M2. CHEMICAL AND PHYSICAL MANIPULATION
The following is prohibited:
1. Falsification or attempted falsification, with the aim of altering the integrity and validity of samples collected during doping control. This category includes, but is not limited to, the substitution and/or alteration of urine (e.g. proteases).
2. Intravenous infusions and/or injections of more than 50 ml per 6-hour period, except those legitimately received in hospital admissions or in clinical examinations.
M3. GENERAL DOPAGE
The following, having the potential capacity to improve sports performance, is prohibited:
1. Transfer of nucleic acid polymers or nucleic acid analogs;
2. Use of normal or genetically modified cells.
SUBSTANCES AND METHODS IN COMPETITION
In addition to the categories S0 to S5 and M1 to M3 defined above, the following categories are prohibited in competition:
SUBSTANCES INTERDITES
S6. STIMULANTS
All stimulants, including all optical isomers (e.g. d- and 1-) where applicable, are prohibited, with the exception of topical application imidazole derivatives and stimulants in the 2014 Monitoring Program*.
Stimulants include:
a. Stimulants not specified:
Adrafinil, amphetamine, amphetamine, amphetamine, amiphenazol, benfluorex, benzylpipérazine, bromantan, clobenzorex, cocaine, cropropamide, fencamine, fenetylline, fenfluramine, fenproporexpira A stimulant that is not specifically named in this section is a specified substance.
b. Specified stimulants (examples):
(e.g. mephedone, methedone, methedone, α-pyrrodone), dimethylamphenamine, ephedrine, fenbutrazate
* Substances in the 2014 Surveillance Program (bupropion, caffeine, nicotine, phenylpropanolamine, pipradrol, synephrine) are not considered prohibited substances.
** Cathine is prohibited when its concentration in the urine exceeds 5 micrograms per millilitre.
*** Ephedrine and methylephedrine are prohibited when their respective concentrations in the urine exceed 10 micrograms per millilitre.
**** Local use (e.g. by nasal or ophthalmological) of the epinephrine (adrenaline) or co-administration with local anesthetic are not prohibited.
***** The pseudoephedrine is prohibited when its concentration in the urine exceeds 150 micrograms per millilitre.
S7. NARCOTIQUES
The following is prohibited:
Buprenorphine, dextromoramide, diamorphine (heroin), fentanyl and its derivatives, hydromorphone, methadone, morphine, oxycodone, oxymorphone, pentazocin, penthidine.
S8. CANNABINOCIDES
Natural Δ9-tetrahydrocannabinol (THC) (e.g. cannabis, haschisch, marijuana) or synthetic, and cannabimimetics (e.g. "Spice", JWH018, JWH073, HU-210) are prohibited.
S9. GLUCOCORTICOÏDES
All glucocorticoids are prohibited when administered by oral, intravenous, intramuscular or rectal.
SUBSTANCES IN SPORTS
P1. ALCOOL
Alcohol (ethanol) is prohibited in competition only in the following sports. The detection will be performed by ethylometry and/or blood analysis. The violation threshold is equivalent to a blood alcohol concentration of 0.10 g/l.
Aeronautics (FAI).
Automobile (FIA).
Karate (WKF).
Motorcycling (FIM).
Motonautique (UIM).
Archery (WA).
P2. BÊTA-BLOQUANTS
Unless otherwise stated, beta-blockers are prohibited in competition only in the following sports:
Automobile (FIA).
Leg (all disciplines) (WCBS).
Darts (WDF).
Golf (IGF).
Ski (FIS) for ski jump, freestyle/halfpipe jump and halfpipe/big air snowboard.
Shooting (ISSF, IPC) (also banned out of competition).
Archery (WA) (also banned out of competition).
Beta-blockers include but are not limited to:
Acebutolol, alprenolol, aténolol, betaxolol, bisoprolol, bunolol, cartéolol, carvedilol, celiprolol, esmolol, labétalol, lévobunolol, metipranolol, metoprolol, nadolol, oxprenolol, pindolol, proptalranolol, so
Done on September 4, 2014.
François Hollande
By the President of the Republic:
The Prime Minister,
Manuel Valls
Minister for Foreign Affairs and International Development,
Laurent Fabius
